ID

34422

Description

Powered Echelon Device in VATS Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT01808430

Lien

https://clinicaltrials.gov/show/NCT01808430

Mots-clés

  1. 17/01/2019 17/01/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed nsclc (up to and including stage ii) for patients undergoing vats lobectomy. for patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from crc, a malignant diagnosis may be confirmed post-operatively.
Description

ID.1

Type de données

boolean

scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
Description

ID.2

Type de données

boolean

willing to give consent and comply with evaluation and treatment schedule
Description

ID.3

Type de données

boolean

at least 18 years of age
Description

ID.4

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
active bacterial infection or fungal infection
Description

ID.5

Type de données

boolean

systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
Description

ID.6

Type de données

boolean

chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
Description

ID.7

Type de données

boolean

scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and vats lymphadenectomy are allowed);
Description

ID.8

Type de données

boolean

prior history of vats or open lung surgery
Description

ID.9

Type de données

boolean

Similar models

Eligibility Non-small Cell Lung Cancer (NSCLC) NCT01808430

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically confirmed nsclc (up to and including stage ii) for patients undergoing vats lobectomy. for patients undergoing wedge resection for undiagnosed pulmonary nodule or metastasis from crc, a malignant diagnosis may be confirmed post-operatively.
boolean
ID.2
Item
scheduled for lung resection surgery (lobectomy or wedge resection) involving only one lobe of the lung
boolean
ID.3
Item
willing to give consent and comply with evaluation and treatment schedule
boolean
ID.4
Item
at least 18 years of age
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
active bacterial infection or fungal infection
boolean
ID.6
Item
systemic administration (intravenous or oral) of steroids (within 30 days prior to study procedure)
boolean
ID.7
Item
chemotherapy or radiation therapy for lung cancer may not be performed for 30 days prior to the procedure
boolean
ID.8
Item
scheduled concurrent surgical procedure other than wedge resection or lobectomy (central venous access - e.g. port placement, mediastinoscopy with lymph node sampling, and vats lymphadenectomy are allowed);
boolean
ID.9
Item
prior history of vats or open lung surgery
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial